| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 135 |
| 1 | METHOTREXATE SODIUM | 127 |
| 2 | ADALIMUMAB | 117 |
| 3 | DUPILUMAB | 110 |
| 4 | PEMBROLIZUMAB | 110 |
| 5 | METHOTREXATE | 104 |
| 6 | PREDNISONE | 93 |
| 7 | LEVOTHYROXINE SODIUM | 86 |
| 8 | ASPIRIN | 85 |
| 9 | ASPIRIN 325 MG | 84 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BULEVIRTIDE | 4 | 0.0417 |
| 1 | DICLOFENAC SODIUM/MISOPROSTOL | 13 | 0.0293 |
| 2 | FROVATRIPTAN SUCCINATE | 17 | 0.0213 |
| 3 | AMCINONIDE | 1 | 0.0118 |
| 4 | TRIMIPRAMINE MALEATE | 4 | 0.0101 |
| 5 | SEVELAMER HYDROCHLORIDE | 5 | 0.0087 |
| 6 | ASPRIN AND CAFFEINE | 1 | 0.0082 |
| 7 | FLURANDRENOLIDE | 2 | 0.0060 |
| 8 | TRANDOLAPRIL TABLETS | 8 | 0.0039 |
| 9 | SELADELPAR LYSINE | 1 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 264 |
| 1 | Corticosteroid [EPC] | 225 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 216 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 192 |
| 4 | Proton Pump Inhibitor [EPC] | 124 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 114 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 110 |
| 7 | Thiazide Diuretic [EPC] | 104 |
| 8 | beta-Adrenergic Blocker [EPC] | 100 |
| 9 | Benzodiazepine [EPC] | 89 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Endoglycosidase [EPC] | 6 | 0.0032 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 264 | 0.0027 |
| 3 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 4 | Interleukin-17A Antagonist [EPC] | 79 | 0.0021 |
| 5 | Provitamin D2 Compound [EPC] | 45 | 0.0015 |
| 6 | Chemokine Receptor Type 4 Interaction [EPC] | 2 | 0.0015 |
| 7 | Rifamycin Antimycobacterial [EPC] | 5 | 0.0014 |
| 8 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 9 | Prostaglandin E1 Analog [EPC] | 18 | 0.0011 |